arrows arrow-right arrow-left menu search rss youtube linkedin twitter facebook arrow-play

Army Chooses Battelle to Create Vaccines and Therapeutics for Biological and Chemical Threats

Posted on May 23, 2016

Homeland Security Today

Battelle has been selected for a $59 million contract from the US Army Joint Program Executive Office for Chemical and Biological to research and develop vaccines and therapeutics for biological and chemical threats.

The five-year contract was awarded through OASIS, the General Service Administration’s newest contracting vehicle open to all Federal Government agencies worldwide.

Read the full story here
.

Media Contacts


Katy Delaney
Director, Media Relations
Office: 1.614.424.7208
Email: delaneyk@battelle.org 


T.R. Massey

Senior Media Specialist
Office: 1.614.424.5544 
Email: masseytr@battelle.org